Transaction · 0001035422-26-000016

CTT PHARMACEUTICAL HOLDINGS, INC.

CTT PHARMACEUTICAL HOLDINGS, INC., CEO, reported an open-market or private purchase at CTT PHARMACEUTICAL HOLDINGS, INC. involving 3700.000000 shares for an estimated $203.50. Reported holdings after the transaction were 9433656.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market buySEC transaction code PCEO
CTTHCTT PHARMACEUTICAL HOLDINGS, INC.
Filing timeOct 06
Trade dateOct 06, 2026
Filing · SECView on SEC
InsiderProfile
% of reported position traded0.04%Shares purchased ÷ (holdings after − shares purchased). Estimated position before: 9,429,956 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
—
Pre-filing
1mo ago1w ago1d ago
Returns since
7d30d90d180d1y

CTTH price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
CTTH since 2026-10-06Filed 2 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Buy
Code P
Identifier
0001035422-26-000016
CTTH
Transaction date
Oct 06, 2026
Filed Oct 06, 2026, 09:24 PM · 0d delay
Shares
3.70k sh
$0.06 per share
Estimated value
$204
Computed from shares × price
Holdings after
9.43M sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
CEO Buy Director Buy Direct Ownership
+34score
Filing-only score

+34

Compact filing score computed from stored Form 4 facts. Version v1.

Strong filing signal

This filing has a high positive filing-only score. It may deserve closer research, but it is not an investment recommendation.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

CEO

Officer YesDirector Yes10% NoOther No
Footnotes & amended

No footnotes recorded.

Original filing · 0001035422-26-000016
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

CTTH